Skip to main content
SpringerLink
Log in

Preventing HIV/AIDS in the United States, 1981–2009: History in the Making

  • Chapter
  • First Online:
The New Public Health and STD/HIV Prevention

Abstract

The history of HIV/AIDS prevention is, without question, a great, unfinished work. True, there have been important milestones in the three decades since the epidemic was first described in the United States [1]—accomplishments in science, advances in policy and the evolution of organized efforts to prevent the spread of the human immunodeficiency virus [2]. Yet, the epidemic is far from over, either in the United States or elsewhere in the world. According to the UNAIDS, there were 33 million people living with HIV in 2007 and almost 3 million new infections that same year [3]. In the United States, an estimated 56,300 persons became newly infected with HIV in 2006—roughly 40 % higher than previous estimates of HIV incidence [4]. Continued gaps in knowledge, notably in the domains of vaccine and microbicide development, have blunted efforts to prevent continued HIV transmission [5] and failure to bring proven HIV prevention interventions and programs to scale [6] has impeded optimal progress.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 84.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 129.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 109.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Centers for Disease Control and Prevention. Pneumocystis pneumonia—Los Angeles. MMWR Morb Mortal Wkly Rep. 1981;30:250–2.

    Google Scholar 

  2. Valdiserri RO. HIV/AIDS in historical profile. In: Valdiserri RO, editor. Dawning answers: How the HIV/AIDS epidemic has helped to strengthen public health. Oxford: Oxford University Press; 2003. p. 3–32.

    Google Scholar 

  3. UNAIDS. 2008 epidemiology slides. http://data.unaids.org/pub/GlobalReport/2008. Accessed 30 Dec 2008.

  4. Hall HI, Song R, Rhodes P, et al. Estimation of HIV incidence in the united states. JAMA. 2008;300:520–9.

    Article  PubMed  CAS  Google Scholar 

  5. Merson MH, O’Malley J, Serwadda D, Apisuk C. The history and challenge of HIV prevention. Lancet. 2008;372:475–88.

    Article  PubMed  Google Scholar 

  6. Global HIV Prevention Working Group. Bringing HIV prevention to scale: an urgent global priority. http://www.globalhivprevention.org/pdfs/PWG-HIV_prevention_report-FINAL.pdf. Accessed 30 Dec 2008.

  7. Valdiserri RO. Preventing AIDS: the design of effective programs. New Brunswick, NJ: Rutgers University Press; 1989.

    Google Scholar 

  8. Gottlieb MS. AIDS—past and future. N Engl J Med. 2001;344:1788–90.

    Article  PubMed  CAS  Google Scholar 

  9. Centers for Disease Control and Prevention. HIV prevalence estimates—United States, 2006. MMWR Morb Mortal Wkly Rep. 2008;57:1073–6.

    Google Scholar 

  10. Centers for Disease Control and Prevention. HIV/AIDS Surveillance Report, 2007, vol. 19. Atlanta: U.S. Department of Health and Human Services, Centers for Disease Control and Prevention; 2009. p. 1–63.

    Google Scholar 

  11. Centers for Disease Control and Prevention. A cluster of Kaposi’s sarcoma and Pneumocystis carinii pneumonia among homosexual male residents of Los Angeles and orange counties, California. MMWR Morb Mortal Wkly Rep. 1982;31:305–7.

    Google Scholar 

  12. Centers for Disease Control and Prevention. Possible transfusion-associated acquired immune deficiency syndrome (AIDS)—California. MMWR Morb Mortal Wkly Rep. 1982;31:652–4.

    Google Scholar 

  13. Centers for Disease Control and Prevention. Prevention of acquired immune deficiency syndrome (AIDS): report of inter-agency recommendations. MMWR Morb Mortal Wkly Rep. 1983;32(8):101–4.

    Google Scholar 

  14. Centers for Disease Control and Prevention. HIV/AIDS Surveillance Report 1994;5(4):1–33.

    Google Scholar 

  15. Hariri S, McKenna MT. Epidemiology of human immunodeficiency virus in the United States. Clin Microbiol Rev. 2007;20:478–88.

    Article  PubMed  Google Scholar 

  16. Centers for Disease Control and Prevention. HIV and AIDS—United States, 1981–2000. MMWR Morb Mortal Wkly Rep. 2001;50:430–4.

    Google Scholar 

  17. Barre-Sinoussi F, Chermann JC, Rey F, et al. Isolation of a T-lymphotropic retrovirus from a patient at risk for acquired immune deficiency syndrome (AIDS). Science. 1983;220:868–71.

    Article  PubMed  CAS  Google Scholar 

  18. Lite J. Montagnier, Barre-Sinoussi and zur Hausen Share Nobel. Scientific American, Oct 6 2008. http://www.sciam.com/article.cfm?id=montagnier-barre-sinoussi%26print=true. Accessed 6 Jan 2009.

  19. Gallo RC, Salahuddin SZ, Popovic M, et al. Frequent detection and isolation of cytopathic retroviruses (HTLV-III) from patients with AIDS and at risk for AIDS. Science. 1984;224:500–3.

    Article  PubMed  CAS  Google Scholar 

  20. Centers for Disease Control and Prevention. Results of human T-lymphotropic virus type III test kits reported from blood collection centers—United States, April 22–May 19 1985. MMWR Morb Mortal Wkly Rep. 1985;34:375–6.

    Google Scholar 

  21. Buehler JW. HIV and AIDS surveillance: public health lessons learned. In: Valdiserri RO, editor. Dawning answers: How the HIV/AIDS epidemic Has helped to strengthen public health. Oxford, England: Oxford University Press; 2003. p. 33–55.

    Google Scholar 

  22. Coffin J, Haase A, Levy JA, et al. Human immunodeficiency viruses. Science. 1986;232:697.

    Article  PubMed  CAS  Google Scholar 

  23. Klevens RN, Hughes D. The impact of transfusion-associated AIDS in the United States. Abstract 769-W. 9th Conference on Retroviruses and Opportunistic Infections. 2002. http://www.retroconference.org/2002/Abstract/13540.htm. Accessed 21 Jan 2009.

  24. Selik RM, Ward JW, Buehler JW. Trends in transfusion-associated acquired immune deficiency syndrome in the United States, 1982 through 1991. Transfusion. 1993;33:890–3.

    Article  PubMed  CAS  Google Scholar 

  25. Gwinn M, Pappaioanou M, George RJ, et al. Prevalence of HIV infection in childbearing women in the United States: surveillance using newborn blood samples. JAMA. 1991;265:1704–8.

    Article  PubMed  CAS  Google Scholar 

  26. Centers for Disease Control and Prevention. National HIV serosurveillance summary: results through 1992, vol. 3. Atlanta, GA: U.S. Department of Health and Human Services; 1994.

    Google Scholar 

  27. Centers for Disease Control and Prevention. Zidovudine for the prevention of HIV transmission from mother to infant. MMWR Morb Mortal Wkly Rep. 1994;43:285–7.

    Google Scholar 

  28. Connor EM, Sperling RS, Gelber R, et al. Reduction of maternal-infant transmission of human immunodeficiency virus type 1 with zidovudine treatment. N Engl J Med. 1994;331:1173–80.

    Article  PubMed  CAS  Google Scholar 

  29. Centers for Disease Control and Prevention. Recommendations for the use of zidovudine to reduce perinatal transmission of human immunodeficiency virus. MMWR Morb Mortal Wkly Rep. 1994;43(No. RR-11):1–20.

    Google Scholar 

  30. Centers for Disease Control and Prevention. U.S. Public Health Service recommendations for human immunodeficiency virus counseling and voluntary testing for pregnant women. MMWR Morb Mortal Wkly Rep. 1995;44(No. RR-7):1–15.

    Google Scholar 

  31. Centers for Disease Control and Prevention. Recommendations for assisting in the prevention of perinatal transmission of human T-lymphotropic virus type III/lymphadenopathy-associated virus and acquired immunodeficiency syndrome. MMWR Morb Mortal Wkly Rep. 1985;34(48):721–32.

    Google Scholar 

  32. Lindegren ML, Byers RH, Thomas P, et al. Trends in perinatal transmission of HIV/AIDS in the United States. JAMA. 1999;282:531–8.

    Article  PubMed  CAS  Google Scholar 

  33. Institute of Medicine, Committee on Perinatal Transmission of HIV. Reducing the odds: preventing perinatal transmission of HIV in the United States. Washington, DC: National Academy Press; 1999.

    Google Scholar 

  34. Centers for Disease Control and Prevention. Achievements in public health: reduction in perinatal transmission of HIV infection—United States, 1985—2005. MMWR Morb Mortal Wkly Rep. 2006;55(21):592–7.

    Google Scholar 

  35. Centers for Disease Control and Prevention. Update: trends in AIDS incidence, deaths, and prevalence—United States, 1996. MMWR Morb Mortal Wkly Rep. 1997;46(8):165–73.

    Google Scholar 

  36. Palella FJ, Delaney KM, Moorman AC, et al. Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. N Engl J Med. 1998;338(13):853–60.

    Article  PubMed  Google Scholar 

  37. Antiretroviral Therapy Cohort Collaboration. Life expectancy of individuals on combination antiretroviral therapy in high-income countries: a collaborative analysis of 14 cohort studies. Lancet. 2008;372:293–9.

    Article  Google Scholar 

  38. Lee LM, Karon JM, Selik R, Neal JJ, Fleming PL. Survival after AIDS diagnosis in adolescents and adults during the treatment era, United States, 1984–1997. JAMA. 2001;285(10):1308–15.

    Article  PubMed  CAS  Google Scholar 

  39. Janssen RS, Valdiserri RO. HIV prevention in the United States: increasing emphasis on working with those living with HIV. J Acquir Immune Defic Syndr. 2004;37(2):S119–21.

    Article  PubMed  Google Scholar 

  40. Centers for Disease Control and Prevention. Subpopulation estimates from the HIV incidence surveillance system—United States, 2006. MMWR Morb Mortal Wkly Rep. 2008;57(36):985–9.

    Google Scholar 

  41. Valdiserri RO. Technology transfer: achieving the promise of HIV prevention. In: Peterson JL, DiClemente RJ, editors. Handbook of HIV prevention. New York, NY: Kluwer Academic/Plenum; 2000. p. 267–83.

    Chapter  Google Scholar 

  42. Centers for Disease Control and Prevention. Kaposi’s sarcoma and Pneumocystis pneumonia among homosexual men—New York city and California. MMWR Morb Mortal Wkly Rep. 1981;30:305–8.

    Google Scholar 

  43. Centers for Disease Control and Prevention. Follow-up on Kapposi’s sarcoma and Pneumocystis pneumonia. MMWR Morb Mortal Wkly Rep. 1981;30:409–10.

    Google Scholar 

  44. Masur H, Michelis MA, Greene JB, et al. An outbreak of community-acquired Pneumocystis carinii pneumonia: initial manifestation of cellular immune dysfunction. N Engl J Med. 1981;305(24):1431–8.

    Article  PubMed  CAS  Google Scholar 

  45. Centers for Disease Control and Prevention. Unexplained immunodeficiency and opportunistic infections in infants—New York, New Jersey, California. MMWR Morb Mortal Wkly Rep. 1982;31:665–7.

    Google Scholar 

  46. Andriote JM. Victory deferred: how AIDS changed Gay life in America. Chicago, IL: University of Chicago Press; 1999.

    Google Scholar 

  47. Leo J. The real epidemic: fear and despair: AIDS isolates many of its victims and is changing the gay life-style. Time Magazine. July 4; 1983. pp. 56–8.

    Google Scholar 

  48. Kinsella J. Covering the plague. New Brunswick, NJ: Rutgers University Press; 1989.

    Google Scholar 

  49. Thomas E. The new untouchables: anxiety over AIDS is verging on hysteria in some parts of the country. Time Magazine, 23 Sep 1985. pp. 24–26.

    Google Scholar 

  50. Centers for Disease Control and Prevention. Acquired immune deficiency syndrome (AIDS): precautions for clinical and laboratory staffs. MMWR Morb Mortal Wkly Rep. 1982;31:577–80.

    Google Scholar 

  51. Centers for Disease Control and Prevention. Antibodies to a retrovirus etiologically associated with acquired immunodeficiency syndrome (AIDS) in populations with increased incidences of the syndrome. MMWR Morb Mortal Wkly Rep. 1984;33:377–9.

    Google Scholar 

  52. Centers for Disease Control and Prevention. Provisional public health service inter-agency recommendations for screening donated blood and plasma for antibody to the virus causing acquired immunodeficiency syndrome. MMWR Morb Mortal Wkly Rep. 1985;34:1–5.

    Google Scholar 

  53. Mason JO. Public health service plan for the prevention and control of acquired immune deficiency syndrome (AIDS). Public Health Rep. 1985;100(5):453–5.

    Google Scholar 

  54. American Public Health Association. Criteria for the development of health promotion and education programs. Am J Public Health. 1987;77:89–92.

    Article  Google Scholar 

  55. Research and Decisions Corporation. Designing an effective AIDS prevention campaign strategy for San Francisco: Results from the first probability sample of an Urban Gay Male Community. 3 Dec 1984, San Francisco, CA.

    Google Scholar 

  56. McKusick L, Horstman W, Coates TJ. AIDS and sexual behavior reported by Gay men in San Francisco. Am J Public Health. 1985;75:493–6.

    Article  PubMed  CAS  Google Scholar 

  57. Wohlfeiler D. Community organizing and community building among Gay and bisexual Men. In: Minkler M, editor. Community organizing and community building for health. New Brunswick, NJ: Rutgers University Press; 1997. p. 230–43.

    Google Scholar 

  58. Centers for Disease Control and Prevention. Evolution of HIV/AIDS prevention programs—United States, 1981–2006. MMWR Morb Mortal Wkly Rep. 2006;55:597–603.

    Google Scholar 

  59. Bailey ME. Community-based organizations and CDC as partners in HIV education and prevention. Public Health Rep. 1991;106:702–8.

    PubMed  CAS  Google Scholar 

  60. Arno PS. The nonprofit sector’s response to the AIDS epidemic: community-based services in San Francisco. Am J Public Health. 1986;76:1325–30.

    Article  PubMed  CAS  Google Scholar 

  61. Palacios-Jimenez SM. Facilitator’s guide to eroticizing safer sex: a psychoeducational workshop approach to safer sex education. New York: Gay Men’s Health Crisis; 1986.

    Google Scholar 

  62. Booth W. Another muzzle for AIDS education? Science. 1987;238:1036.

    Article  PubMed  CAS  Google Scholar 

  63. Kolata G. Erotic films in AIDS study cut risky behavior. New York Times, 3 Nov 1987. p. 18.

    Google Scholar 

  64. Johnson JA. AIDS funding for federal government programs: FY1981—FY2009. Congressional Research Service. 23 Apr 2008. http://assets.opencrs.com/rpts/RL30731_20080423.pdf. Accessed 4 Mar 2009.

  65. Fineberg HV. Education to prevent AIDS: prospects and obstacles. Science. 1988;239:592–6.

    Article  PubMed  CAS  Google Scholar 

  66. Centers for Disease Control and Prevention. Content of AIDS-related materials, pictorials, audiovisuals, questionnaires, survey instruments, and educational sessions in Centers for Disease Control and Prevention (CDC) assistance programs. http://www.cdc.gov/od/pgo/forms/hiv.htm. Accessed 4 Mar 2009.

  67. U.S. Public Health Service Executive Task Force on AIDS. Coolfont report: a PHS plan for prevention and control of AIDS and the AIDS virus. Public Health Rep. 1986;101:341–8.

    Google Scholar 

  68. Hartgers C, Ameijden EJ, Hoek JA, Coutinho RA. Needle sharing and participation in the Amsterdam Syringe Exchange Program among HIV-seronegative injecting drug users. Public Health Rep. 1992;107:675–81.

    PubMed  CAS  Google Scholar 

  69. Strathdee SA, Vlahov D. The effectiveness of needle exchange programs: a review of the science and policy. AIDScience. 2001; 1(16). http://aidscience.org/Articles/aidscience013.12p. Accessed 12 Mar 2009.

  70. Gostin LO. The legal environment impeding access to sterile syringes and needles: the conflict between law enforcement and public health. J Acquir Immune Defic Syndr. 1998;18 Suppl 1:S60–70.

    Google Scholar 

  71. Lane SD. A brief history. In: Stryker J, Smith M, editors. Dimensions of HIV prevention: needle exchange. Menlo Park, CA: Henry J. Kaiser Family Foundation; 1993. p. 1–9.

    Google Scholar 

  72. Thomas SB, Quinn SC. The burdens of race and history on Black Americans’ attitudes toward needle exchange policy to prevent HIV disease. J Public Health Policy. 1993;14:320–47.

    Article  PubMed  CAS  Google Scholar 

  73. Committee on the Prevention of HIV Infection among Injection Drug Users in High Risk Countries. Preventing HIV infection among injecting drug users in high-risk countries: an assessment of the evidence. Washington, DC: National Academies Press; 2007.

    Google Scholar 

  74. Wodak A, Cooney A. Do needle syringe programs reduce HIV infection among injecting drug users: a comprehensive review of the international evidence. Subst Use Misuse. 2006;4(1):777–813.

    Article  Google Scholar 

  75. Hurley SF, Jolley DJ, Kaldor JM. Effectiveness of needle-exchange programmes for prevention of HIV infection. Lancet. 1997;349:1797–800.

    Article  PubMed  CAS  Google Scholar 

  76. Des Jarlais DC, Hagan H, Friedman SR, et al. Maintaining low HIV seroprevalence in populations of injecting drug users. JAMA. 1995;274:1226–31.

    Article  PubMed  CAS  Google Scholar 

  77. Centers for Disease Control and Prevention. Syringe exchange programs—United States, 2005. MMWR Morb Mortal Wkly Rep. 2007;56:1164–7.

    Google Scholar 

  78. Schwartzapfel B. Swapping politics for science on drug policy. The Nation. 12/21/2009. http://www.thenation.com/doc/20100104/schwartzapfel/print. Accessed on 3 Mar 2010.

  79. Centers for Disease Control and Prevention. Impact of new legislation on needle and syringe purchase and possession—Connecticut, 1992. MMWR Morb Mortal Wkly Rep. 1993;42:145–8.

    Google Scholar 

  80. Valleroy LA, Weinstein B, Jones TS, Groseclose SL, Rolfs RT, Kassler WJ. Impact of increased legal access to needles and syringes on community pharmacies’ needle and syringe sales—Connecticut, 1992–1993. J Acquir Immune Defic Syndr. 1995;10:73–81.

    CAS  Google Scholar 

  81. Groseclose SL, Weinstein B, Jones TS, Valleroy LA, Fehrs LJ, Kassler WJ. Impact of increased legal access to needles and syringes on practices of injecting-drug users and police officers—Connecticut, 1992–1993. J Acquir Immune Defic Syndr. 1995;10:82–9.

    CAS  Google Scholar 

  82. Compton WM, Horton JC, Cottler LB, et al. A multistate trial of pharmacy syringe purchase. J Urban Health. 2004;81:661–70.

    Article  PubMed  Google Scholar 

  83. Deibert RJ, Goldbaum G, Parker TR, et al. Increased access to unrestricted pharmacy sales of syringes in Seattle-king county, Washington: structural and individual-level changes, 1996 versus 2003. Am J Public Health. 2006;96:1347–53.

    Article  PubMed  Google Scholar 

  84. Fuller CM, Galea S, Caceres W, Blaney S, Sisco S, Vlahov D. Multilevel community-based intervention to increase access to sterile syringes among injection drug users through pharmacy sales in New York city. Am J Public Health. 2007;97:117–24.

    Article  PubMed  Google Scholar 

  85. Gibson DR, Flynn NM, McCarthy JJ. Effectiveness of methadone treatment in reducing HIV risk behavior and HIV seroconversion among injecting drug users. AIDS. 1999;13:1807–18.

    Article  PubMed  CAS  Google Scholar 

  86. Williams AB, McNelly EA, Williams AE, D’Aquila RT. Methadone maintenance treatment and HIV type 1 seroconversion among injecting drug users. AIDS Care. 1992;4:35–41.

    Article  PubMed  Google Scholar 

  87. Metzger DS, Woody GE, McLellan T. Human immunodeficiency virus seroconversion among intravenous drug users in- and out-of-treatment: an 18 month prospective follow-up. J Acquir Immune Defic Syndr. 1993;6:1049–56.

    PubMed  CAS  Google Scholar 

  88. Metzger DS, Navaline H, Woody GE. Drug abuse treatment as AIDS prevention. Public Health Rep. 1998;113 Suppl 1:97–106.

    PubMed  Google Scholar 

  89. Kleber HD. Methadone maintenance 4 decades later: thousands of lives saved but still controversial. JAMA. 2008;300:2303–5.

    Article  PubMed  CAS  Google Scholar 

  90. Des Jarlais DC, Paone D, Friedman SR, Peyser N, Newman RG. Regulating controversial programs for unpopular people: methadone maintenance and syringe exchange programs. Am J Public Health. 1995;85:1577–84.

    Article  PubMed  CAS  Google Scholar 

  91. Centers for Disease Control and Prevention. HIV diagnoses among injection-drug users in states with HIV surveillance—25 States, 1994–2000. MMWR Morb Mortal Wkly Rep. 2003;52:634–6.

    Google Scholar 

  92. Centers for Disease Control and Prevention. Trends in HIV/AIDS diagnoses—33 states, 2001–2004. MMWR Morb Mortal Wkly Rep. 2005;54:1149–53.

    Google Scholar 

  93. Des Jarlais DC, Marmor M, Friedmann P, et al. HIV incidence among injection drug users in New York city, 1992–1997: evidence for a declining epidemic. Am J Public Health. 2000;90:352–9.

    Article  PubMed  CAS  Google Scholar 

  94. Des Jarlais DC, Arasteh K, Perlis T, et al. Converging of HIV seroprevalence among injecting and non-injecting drug users in New York city. AIDS. 2007;21:231–5.

    Article  PubMed  Google Scholar 

  95. Brandt A. AIDS in historical perspective: four lessons from the history of sexually transmitted diseases. Am J Public Health. 1988;78:367–71.

    Article  PubMed  CAS  Google Scholar 

  96. Brandt A. No magic bullet: a social history of venereal disease in the United States since 1880. New York, NY: Oxford University Press; 1985.

    Google Scholar 

  97. Institute of Medicine, Committee on a National Strategy for AIDS. Confronting AIDS: directions for public health, health care and research. Washington, DC: National Academy Press; 1986.

    Google Scholar 

  98. Valdiserri RO. Epidemics in perspective. J Med Humanit Bioeth. 1987;8:95–100.

    Article  PubMed  CAS  Google Scholar 

  99. Kosterlitz J. Educating about AIDS. Natl J Aug 30, 1986; 35:2044–9.

    Google Scholar 

  100. Woods D, David D, Westover FJ. “America Responds to AIDS:” its content, process and outcome. Public Health Rep. 1991;106:616–22.

    PubMed  CAS  Google Scholar 

  101. Keiser NH. Strategies of media marketing for “American Responds to AIDS” and applying lessons learned. Public Health Rep. 1991;106:623–7.

    PubMed  CAS  Google Scholar 

  102. Centers for Disease Control and Prevention. Understanding AIDS: an information brochure being mailed to all U.S. households. MMWR Morb Mortal Wkly Rep. 1988;37:261–9.

    Google Scholar 

  103. Mason JO, Noble GR, Lindsey BK, et al. Current CDC efforts to prevent and control human immunodeficiency virus infection and AIDS in the United States through information and education. Public Health Rep. 1988;103:255–60.

    PubMed  CAS  Google Scholar 

  104. Centers for Disease Control and Prevention. Guidelines for effective school health education to prevent the spread of AIDS. MMWR Morb Mortal Wkly Rep. 1988;37(S-2):1–14.

    Google Scholar 

  105. Office of Technology Assessment, U.S. Congress. Review of the public health service’s response to AIDS. Washington, DC: U.S. Congress Office of Technology Assessment, OTA-TM-H-24; February 1985.

    Google Scholar 

  106. Panem S. The AIDS bureaucracy. Cambridge, MA: Harvard University Press; 1988.

    Google Scholar 

  107. Institute of Medicine. The AIDS Research Program of the National Institutes of Health. Washington, DC: National Academies Press; 1991.

    Google Scholar 

  108. U.S. General Accounting Office. AIDS Education: Reaching Populations at Higher Risk; Report to the Chairman, Committee on Governmental Affairs, U.S. Senate. Washington, DC: U.S. General Accounting Office; September 1988 (PEMD-88-35).

    Google Scholar 

  109. Lorig K, Laurin J. Some notions about assumptions underlying health education. Health Educ Q. 1985;12:231–43.

    Article  PubMed  CAS  Google Scholar 

  110. McGinnis JM. Recent history of federal initiatives in prevention policy. Am Psychol. 1985;40:205–12.

    Article  PubMed  CAS  Google Scholar 

  111. Minkler M. Health education, health promotion and the open society: an historical perspective. Health Educ Q. 1989;16:17–30.

    Article  PubMed  CAS  Google Scholar 

  112. Leviton LC. Theoretical foundations of AIDS-prevention programs. In: Valdiserri RO, editor. Preventing AIDS: the design of effective programs. New Burnswick, NJ: Rutgers University Press; 1989.

    Google Scholar 

  113. Centers for Disease Control and Prevention. Compendium of HIV prevention interventions with evidence of effectiveness, March 1999:1–57. http://www.cdc.gov/resources/reports/hiv_compendium/index.htm. Accessed 24 Mar 2009.

  114. Kelly JA, Lawrence JS, Hood HV, Brasfield TL. Behavioral intervention to reduce AIDS risk activities. J Consult Clin Psychol. 1989;57:60–7.

    Article  PubMed  CAS  Google Scholar 

  115. Valdiserri RO, Lyter DW, Leviton LC, Callahan CM, Kingsley LA, Rinaldo CR. AIDS prevention in homosexual and bisexual men: results of a randomized trial evaluating two risk reduction interventions. AIDS. 1989;3:21–6.

    PubMed  CAS  Google Scholar 

  116. Institute of Medicine. Confronting AIDS: update 1988. Washington, DC: National Academy Press; 1988.

    Google Scholar 

  117. Turner CF, Miller HG, Moses LE, editors. AIDS: sexual behavior and intravenous drug Use. Washington, DC: National Academy Press; 1989.

    Google Scholar 

  118. Miller HG, Turner CF, Moses LE, editors. AIDS: the second decade. Washington, DC: National Academy Press; 1990.

    Google Scholar 

  119. Coyle SL, Boruch RF, Turner CF, editors. Evaluating AIDS Prevention Programs: expanded edition. Washington, DC: National Academy Press; 1991.

    Google Scholar 

  120. Kelly JA, Murphy DA, Sikkema KJ, Kalichman SC. Psychological interventions to prevent HIV infection are urgently needed: new priorities for behavioral research in the second decade of AIDS. Am Psychol. 1993;48:1023–34.

    Article  PubMed  CAS  Google Scholar 

  121. Auerbach JD, Wypijewska C, Brodie HK, editors. AIDS and behavior: an integrated approach. Washington, DC: National Academy Press; 1994.

    Google Scholar 

  122. Higgins DL, Galavotti C, O’Reilly K, Sheridan J. Evolution and development of the aids community demonstration projects. In: Corby NH, Wolitski RJ, editors. Community HIV prevention: the Long Beach AIDS Community Demonstration Projects. Long Beach, CA: California State University Press; 1997. p. 5–20.

    Google Scholar 

  123. O’Reilly KR, Higgins DL. AIDS Community Demonstration Projects for HIV prevention among hard-to-reach groups. Public Health Rep. 1991;106:714–20.

    PubMed  Google Scholar 

  124. Centers for Disease Control and Prevention. Community-level prevention of human immunodeficiency virus infection among high-risk populations: The AIDS Community Demonstration Projects. MMWR Morb Mortal Wkly Rep. 1996;45(RR-6):1–24.

    Google Scholar 

  125. CDC AIDS Community Demonstration Projects Research Group. Community-level HIV intervention in 5 cities: final outcome data from the CDC AIDS Community Demonstration Projects. Am J Public Health. 1999;89:336–45.

    Article  Google Scholar 

  126. Centers for Disease Control and Prevention, National Institutes of Health, Center for Substance Abuse Treatment. Statement on the role of bleach in HIV prevention programs for injecting drug users (IDUs). 5 May 1993. http://www.aegis.com/pubs/Cdc_Fact_Sheets/1993/CDC93150.html. Accessed 4 Feb 2009.

  127. Kirby D, Barth RP, Leland N, Fetro JV. Reducing the risk: impact of a new curriculum on sexual risk-taking. Fam Plann Perspect. 1991;23:253–63.

    Article  PubMed  CAS  Google Scholar 

  128. Jemmott JB, Jemmott LS, Fong GT. Reductions in HIV risk-associated sexual behaviors among black male adolescents: effects of an AIDS prevention intervention. Am J Public Health. 1992;82:372–7.

    Article  PubMed  Google Scholar 

  129. St. Lawrence JS, Brasfield TL, Jefferson KW, Alleyne E, O’Bannon RE, Shirley A. Cognitive-behavioral intervention to reduce African American adolescents’ risk for HIV infection. J Consult Clin Psychol. 1995;63:221–37.

    Article  PubMed  CAS  Google Scholar 

  130. Jemmott JB, Jemmott LS, Fong GT. Abstinence and safer sex HIV risk-reduction interventions for African American adolescents. JAMA. 1998;279:1529–36.

    Article  PubMed  Google Scholar 

  131. DesJarlais DC, Casriel C, Friedman SR, Rosenblum A. AIDS and the transition to illicit drug injection—results of a randomized trial prevention program. Br J Addict. 1992;87:493–8.

    Article  CAS  Google Scholar 

  132. McCusker J, Stoddard AM, Zapka JG, Morrison CS, Zorn M, Lewis BF. AIDS education for drug abusers: evaluation of short-term effectiveness. Am J Public Health. 1992;82:533–40.

    Article  PubMed  CAS  Google Scholar 

  133. El-Bassel N, Schilling RF. 15 month followup of women methadone patients taught skills to reduce heterosexual HIV transmission. Public Health Rep. 1992;107:500–4.

    PubMed  CAS  Google Scholar 

  134. Siegal HA, Falck RS, Carlson RG, Wang J. Reducing HIV needle risk behaviors among injection-drug users in the midwest: an evaluation of the efficacy of standard and enhanced interventions. AIDS Educ Prev. 1995;7:308–19.

    PubMed  CAS  Google Scholar 

  135. Kelly JA, St. Lawrence JS, Stevenson Y, et al. Community AIDS/HIV risk reduction: the effects of endorsements by popular people in three cities. Am J Public Health. 1992;82:1483–9.

    Article  PubMed  CAS  Google Scholar 

  136. Kegeles SM, Hays RB, Coates TJ. The Mpowerment Project: a community-level HIV prevention intervention for young gay men. Am J Public Health. 1996;86:1129–36.

    Article  PubMed  CAS  Google Scholar 

  137. Kelly JA, Murphy DA, Washington CD, et al. The effects of HIV/AIDS intervention groups for high-risk women in urban clinics. Am J Public Health. 1994;84:1918–22.

    Article  PubMed  CAS  Google Scholar 

  138. DiClemente RJ, Wingood GM. A randomized controlled trial of an HIV sexual risk-reduction intervention for young African-American women. JAMA. 1995;274:1271–6.

    Article  PubMed  CAS  Google Scholar 

  139. Lauby JL, Smith PJ, Stark M, Person B, Adams J. A community-level HIV prevention intervention for inner-city women: results of the women and infants demonstration projects. Am J Public Health. 2000;90:216–22.

    Article  PubMed  CAS  Google Scholar 

  140. Watkins JD. Report of the presidential commission on the human immunodeficiency virus epidemic. Washington, DC: U.S. Government Printing Office; 1988.

    Google Scholar 

  141. Osborn JE. AIDS: an expanding tragedy: the final report of the National Commission on AIDS. Washington, DC: U.S. Government Printing Office; 1993.

    Google Scholar 

  142. Bleakley A, Hennessy M, Fishbein M. Public opinion on sex education in US schools. Arch Pediatr Adolesc Med. 2006;160:1151–6.

    Article  PubMed  Google Scholar 

  143. Darroch JE, Landry DJ, Singh S. Changing emphases in sexuality education in U.S. Public Secondary Schools, 1988–1999. Fam Plann Perspect. 2000;32:204–11. & 265.

    Article  PubMed  CAS  Google Scholar 

  144. Landry DJ, Darroch JE, Singh S, Higgins J. Factors associated with the contents of sex education in U.S. public secondary schools. Perspect Sex Reprod Health. 2003;35:261–9.

    Article  PubMed  Google Scholar 

  145. Lindau ST, Tetteh AS, Kasza K, Gilliam M. What schools teach our patients about sex: content, quality and influences on sex education. Obstet Gynecol. 2008;111:256–66.

    Article  PubMed  Google Scholar 

  146. O’Donnell L, O’Donnell CR, Stueve A. Early sexual initiation and subsequent sex-related risks among urban minority youth: the reach for health study. Fam Plann Perspect. 2001;33:268–75.

    Article  PubMed  Google Scholar 

  147. Resnick MD, Blum RW. The association of consensual sexual intercourse during childhood with adolescent health risk and behaviors. Pediatrics. 1994;94:907–13.

    PubMed  CAS  Google Scholar 

  148. Santelli J, Ott MA, Lyon M, Rogers J, Summers D, Schleifer R. Abstinence and abstinence-only education: a review of U.S. policies and programs. J Adolesc Health. 2006;38:72–81.

    Article  PubMed  Google Scholar 

  149. Society for Adolescent Medicine. Abstinence-only education policies and programs: a position paper of the Society for Adolescent Medicine. J Adolesc Health. 2006;38:83–7.

    Article  Google Scholar 

  150. Kirby DB. The impact of abstinence and comprehensive sex and STD/HIV education programs on adolescent sexual behavior. Sex Res Soc Policy. 2008;5:18–27.

    Article  Google Scholar 

  151. Robin L, Dittus P, Whitaker D, et al. Behavioral interventions to reduce incidence of HIV, STD, and pregnancy among adolescents: a decade in review. J Adolesc Health. 2004;34:3–26.

    Article  PubMed  Google Scholar 

  152. Kann L, Telljohann SK, Wooley SF. Health education: results from the school health policies and programs study 2006. J School Health. 2007;77:408–34.

    Article  PubMed  Google Scholar 

  153. Centers for Disease Control and Prevention. Trends in HIV- and STD-related risk behaviors among high school students—United States, 1991–2007. MMWR Morb Mortal Wkly Rep. 2008;57:817–22.

    Google Scholar 

  154. Centers for Disease Control and Prevention. Acquired immunodeficiency syndrome in correctional facilities: a report of the National Institute of Justice and the American Correctional Association. MMWR Morb Mortal Wkly Rep. 1986;35:195–9.

    Google Scholar 

  155. Valdiserri EV, Hartl AJ, Chamblis CA. Practices reported by incarcerated drug abusers to reduce risk of AIDS. Hosp Community Psychiatry. 1988;39:966–72.

    PubMed  CAS  Google Scholar 

  156. Schilling R, El-Bassel N, Ivanoff A, Gilbert L, Su KH, Safyer SM. Sexual risk behavior of incarcerated, drug-using women, 1992. Public Health Rep. 1994;109:539–47.

    PubMed  CAS  Google Scholar 

  157. Brewer TF, Vlahov D, Taylor E, Hall D, Munoz A, Polk BF. Transmission of HIV-1 within a statewide prison system. AIDS. 1988;2:363–7.

    Article  PubMed  CAS  Google Scholar 

  158. Braithwaite RL, Hammett RM, Mayberry RM. Prisons and AIDS: a public health challenge. San Francisco, CA: Jossey-Bass Publishers; 1996.

    Google Scholar 

  159. Centers for Disease Control and Prevention. HIV transmission among male inmates in a state prison system—Georgia, 1992—2005. MMWR Morb Mortal Wkly Rep. 2006;55:421–6.

    Google Scholar 

  160. National Commission on AIDS. HIV disease in correctional facilities. Washington, DC: National Commission on AIDS; 1991.

    Google Scholar 

  161. Brewer TF, Derrickson J. AIDS in prison: a review of epidemiology and preventive policy. AIDS. 1992;6:623–8.

    Article  PubMed  CAS  Google Scholar 

  162. Polonsky S, Kerr S, Harris B, Gaiter J, Fichtner RR, Kennedy MG. HIV prevention in prisons and jails: obstacles and opportunities. Public Health Rep. 1994;109:615–25.

    PubMed  CAS  Google Scholar 

  163. May JP, Williams EL. Acceptability of condom availability in a U.S. Jail. AIDS Educ Prev. 2002;14(Suppl B):85–91.

    Article  PubMed  Google Scholar 

  164. Hammett TM, Gaiter JL, Crawford C. Reaching seriously at-risk populations: health interventions in criminal justice settings. Health Educ Behav. 1998;25:99–120.

    Article  PubMed  CAS  Google Scholar 

  165. Jurgens R, Ball A, Verster A. Interventions to reduce HIV transmission related to injecting drug use in prison. Lancet Infect Dis. 2009;9:57–66.

    Article  PubMed  Google Scholar 

  166. National Institutes of Health Consensus Development Panel. The impact of routine HTLV-III antibody testing on public health. In: NIH Consensus Develop Conf Statement, 7–9 Jul. Vol 6(5); 1986.

    Google Scholar 

  167. Centers for Disease Control and Prevention. Human T-lymphotropic virus type III/ lymphadenopathy-associated virus antibody testing at alternate sites. MMWR Morb Mortal Wkly Rep. 1986;35:284–7.

    Google Scholar 

  168. Valdiserri RO. HIV counseling and testing: its evolving role in HIV prevention. AIDS Educ Prev. 1997;9(Suppl B):2–13.

    PubMed  CAS  Google Scholar 

  169. Centers for Disease Control and Prevention. Additional recommendations to reduce sexual and drug abuse-related transmission of human T-lymphotropic virus type III/ lymphadenopathy-associated virus. MMWR Morb Mortal Wkly Rep. 1986;35:152–5.

    Google Scholar 

  170. Centers for Disease Control and Prevention. Public Health Service guidelines for counseling and antibody testing to prevent HIV infection and AIDS. MMWR Morb Mortal Wkly Rep. 1987;36:509–15.

    Google Scholar 

  171. Wasserheit JN, Valdiserri RO, Wood RW. Assessment of STD/HIV prevention programs in the United States: national, local, and community perspectives. In: Holmes KK, Sparling PF, Mardh PA, Lemon SM, Stamm WE, Piot P, Wasserheit JN, editors. Sexually transmitted diseases. New York, NY: McGraw-Hill; 1999. p. 1255–71.

    Google Scholar 

  172. Holtgrave DR, Qualls NL, Curran JW, Valdiserri RO, Guinan ME, Parra WC. An overview of the effectiveness and efficiency of HIV prevention programs. Public Health Rep. 1995;110:134–46.

    PubMed  CAS  Google Scholar 

  173. U.S. General Accounting Office. AIDS Prevention Programs: high-risk groups still prove hard to reach. Washington, DC: U.S. General Accounting Office; 1991. HRD-91-52.

    Google Scholar 

  174. American Public Health Association. Special initiative on AIDS. HIV antibody testing. Washington, DC: American Public Health Association; 1989. p. 1–14.

    Google Scholar 

  175. Higgins DL, Galavotti C, O’Reilly KR, et al. Evidence for the effects of HIV antibody counseling and testing on risk behavior. JAMA. 1991;266:2419–29.

    Article  PubMed  CAS  Google Scholar 

  176. Weinhardt LS, Carey MP, Johnson BT, Bickham NL. Effects of HIV counseling and testing on sexual behavior: a meta-analytic review of published research, 1985–1997. Am J Public Health. 1999;89:1397–405.

    Article  PubMed  CAS  Google Scholar 

  177. Centers for Disease Control and Prevention. Technical guidance on HIV Counseling. MMWR Morb Mortal Wkly Rep. 1993;42(RR-2):8–17.

    Google Scholar 

  178. Kamb ML, Fishbein M, Douglas JM, et al. Efficacy of risk-reduction counseling to prevent human immunodeficiency virus and sexually transmitted diseases: a randomized controlled trial. JAMA. 1998;280:1161–7.

    Article  PubMed  CAS  Google Scholar 

  179. Valdiserri RO, Aultman TV, Curran JW. Community planning: a national strategy to improve HIV prevention programs. J Community Health. 1995;20:87–100.

    Article  PubMed  CAS  Google Scholar 

  180. Holtgrave DR, Valdiserri RO. Year one of HIV prevention community planning: a national perspective on accomplishments, challenges and future directions. J Public Health Manag Pract. 1996;2:1–9.

    PubMed  CAS  Google Scholar 

  181. AIDS Action Foundation. A blueprint for reforming federal AIDS prevention programs. Washington, DC: AIDS Action Foundation; 1993. p. 1–26.

    Google Scholar 

  182. Association of State and Territorial Health Officials, Council of State and Territorial Epidemiologists, National Alliance of State and Territorial AIDS Directors. State health agency vision for HIV prevention. Washington, DC: Association of State and Territorial Health Officials; 1993. p. 1–10.

    Google Scholar 

  183. Office of Technology Assessment. External review of the federal centers for disease control and prevention’s HIV prevention programs: summary and overview. Washington, DC: Office of Technology Assessment; 1994. p. 1–25.

    Google Scholar 

  184. Holtgrave DR. Setting priorities and community planning for HIV-prevention programs. AIDS Public Policy. 1994;9:145–51.

    Google Scholar 

  185. Kelly J, Effective HIV. Prevention community planning: an assessment of state initiatives. Washington, DC: National Alliance of State and Territorial AIDS Directors; 1994. p. 1–25.

    Google Scholar 

  186. Schietinger H, Coburn J, Levi J. Community planning for HIV prevention: findings from the first year. AIDS Public Policy. 1995;10:140–7.

    Google Scholar 

  187. Holtgrave DR, Harrison J, Gerber RA, Aultman TV, Scarlett M. Methodological issues in evaluating HIV prevention community planning. Public Health Rep. 1996;111:108–14.

    PubMed  Google Scholar 

  188. Collins C, Franks P. Improving the use of behavioral research in CDC’s HIV prevention community planning process. San Francisco, CA: Center for AIDS Prevention Studies, University of California San Francisco; 1996. p. 1–17.

    Google Scholar 

  189. Valdiserri RO. Managing system-wide change in HIV prevention programs: a CDC perspective. Public Admin Rev. 1996;56:545–53.

    Article  Google Scholar 

  190. Bau I. Asians and Pacific islanders and HIV prevention community planning. AIDS Educ Prev. 1998;10(Suppl A):77–93.

    PubMed  CAS  Google Scholar 

  191. Valdiserri RO, Robinson C, Lin LS, West GR, Holtgrave DR. Determining allocations for HIV prevention interventions: assessing a change in Federal Funding Policy. AIDS Public Policy. 1997;12:138–48.

    CAS  Google Scholar 

  192. Kreuter MW. PATCH: its origin, basic concepts, and links to contemporary public health policy. J Health Educ. 1992;23:135–9.

    Google Scholar 

  193. Jenkins RA, Carey JW. Decision making for HIV prevention planning: organizational considerations and influencing factors. AIDS Behav. 2005;9:S1–8.

    Article  PubMed  Google Scholar 

  194. Jenkins RA, Averbach AR, Robbins A, et al. Improving the use of data for HIV prevention decision making: lessons learned. AIDS Behav. 2005;9:S87–99.

    Article  PubMed  Google Scholar 

  195. Mejia R, Jenkins RA, Carey JW, et al. Longitudinal observation of an HIV prevention community planning group (CPG). Health Promot Pract. 2009;10:136–43.

    Article  PubMed  Google Scholar 

  196. Freudenberg N, Lee J, Silver D. How Black and Latino community organizations respond to the AIDS epidemic: a case study in One New York city neighborhood. AIDS Educ Prev. 1989;1:12–21.

    PubMed  CAS  Google Scholar 

  197. Valdiserri RO, West GR, Moore M, Darrow WW, Hinman AR. Structuring HIV prevention service delivery systems on the basis of social science theory. J Community Health. 1992;17:259–69.

    Article  PubMed  CAS  Google Scholar 

  198. Freudenberg N, Trinidad U. The role of community organizations in AIDS prevention in two Latino communities in New York city. Health Educ Q. 1992;19:219–32.

    Article  PubMed  CAS  Google Scholar 

  199. Chillag K, Bartholow K, Cordeiro J, et al. Factors affecting the delivery of HIV/AIDS prevention programs by community-based organizations. AIDS Educ Prev. 2002;14(Suppl A):27–37.

    Article  PubMed  Google Scholar 

  200. DiFranceisco W, Kelly JA, Otto-Salaj L, et al. Factors influencing attitudes within aids service organizations toward the use of research-based HIV prevention interventions. AIDS Educ Prev. 1999;11:72–86.

    PubMed  CAS  Google Scholar 

  201. Somlai AM, Kelly JA, Otto-Salaj L, et al. Current HIV prevention activities for women and Gay men among 77 ASOs. J Public Health Manag Pract. 1999;5:23–33.

    PubMed  CAS  Google Scholar 

  202. Freudenberg N, Eng E, Flay B, Parcel G, Rogers T, Wallerstein N. Strengthening individual and community capacity to prevent disease and promote health: in search of relevant theories and principles. Health Educ Q. 1995;22:290–306.

    Article  PubMed  CAS  Google Scholar 

  203. Walsh C, Campbell C, Willingham M. HIV/STD prevention program assessments, U.S. Abstract PO-D36-4382. IX International Conference on AIDS. 6–11 Jun 1993, Berlin; 1992.

    Google Scholar 

  204. National Alliance of State and Territorial AIDS Directors. Technical assistance and capacity building assistance for minority communities: a report from the NASTAD STATUS Project. Washington, DC: National Alliance of State and Territorial AIDS Directors; 2001. p. 1–30.

    Google Scholar 

  205. American Psychological Association. Behavioral science expertise needed for HIV prevention community planning. Psychology AIDS Exchange. 1996; 20:7.

    Google Scholar 

  206. Veniegas RC, Kao UH, Rosales R, Arellanes M. HIV prevention technology transfer: challenges and strategies in the real world. Am J Public Health. 2009;99:S124–30.

    Article  PubMed  Google Scholar 

  207. Taveras S, Duncan T, Gentry D, Gilliam A, Kimbrough I, Minaya J. The evolution of the CDC HIV prevention capacity-building assistance initiative. J Public Health Manag Pract. 2007;13:S8–S15.

    Google Scholar 

  208. Miller RL, Bedney BJ, Guenther-Grey C. Assessing organizational capacity to deliver HIV prevention services collaboratively: tales from the field. Health Educ Behav. 2003;30:582–600.

    Article  PubMed  Google Scholar 

  209. Kraft JM, Mezoff JS, Sogolow ED, Neumann MS, Thomas PA. A technology transfer model for effective HIV/AIDS interventions: science and practice. AIDS Educ Prev. 2000;12(Suppl A):7–20.

    PubMed  CAS  Google Scholar 

  210. Richter DL, Potts LH, Prince MS, et al. Development of a curriculum to enhance community-based organizations’ capacity for effective HIV prevention programming and management. AIDS Educ Prev. 2006;18:362–74.

    Article  PubMed  Google Scholar 

  211. Kelly JA, Somlai AM, DiFranceisco WJ, et al. Bridging the gap between the science and service of HIV prevention: transferring effective research-based HIV prevention interventions to community AIDS service providers. Am J Public Health. 2000;90:1082–8.

    Article  PubMed  CAS  Google Scholar 

  212. Copenhaven MM, Fisher JD. Experts outline ways to decrease the decade-long yearly rate of 40,000 new HIV infections in the US. AIDS Behav. 2006;10:105–14.

    Article  Google Scholar 

  213. Valdiserri RO. Mapping the roots of HIV/AIDS complacency: implications for program and policy development. AIDS Educ Prev. 2004;16:426–39.

    Article  PubMed  Google Scholar 

  214. Kaiser Family Foundation. 2009 Survey of Americans on HIV/AIDS: summary of findings on the domestic epidemic; 2009. http://www.kff.org/kaiserpolls/upload/7889.pdf. Accessed 5/11/09.

  215. U.S. Census Bureau News. An Older and More Diverse Nation by Midcentury. August 14, 2008. Available at: http://www.census.gov/Press-Release/www/releases/archives/population/012496.html. Accessed on 12 May 2009.

  216. Adimora AA, Schoenbach VJ, Doherty IA. Concurrent sexual partnerships among Men in the United States. Am J Public Health. 2007;97:2230–7.

    Article  PubMed  Google Scholar 

  217. Adimora AA, Schoenbach VJ, Martinson FE, et al. Heterosexually transmitted HIV infection among African Americans in North Carolina. J Acquir Immune Defic Syndr. 2006;41:616–23.

    Article  PubMed  Google Scholar 

  218. Adimora AA, Schoenbach VJ, Martinson F, Donaldson KH, Stancil TR, Fullilove RE. Concurrent sexual partnerships among African Americans in the rural south. Ann Epidemiol. 2004;14:155–60.

    Article  PubMed  Google Scholar 

  219. Millett GA, Flores SA, Peterson JL, Bakeman R. Explaining disparities in HIV infection among Black and White men: a meta-analysis of HIV risk behaviors. AIDS. 2007;21:2083–91.

    Article  PubMed  Google Scholar 

  220. Centers for Disease Control and Prevention. HIV infection among young Black men who have sex with men—Jackson, Mississippi, 2006–2008. MMWR Morb Mortal Wkly Rep. 2009;58:77–81.

    Google Scholar 

  221. Centers for Disease Control and Prevention. HIV prevalence, unrecognized infection, and HIV testing among men who have sex with men—five U.S. cities, June 2004–April 2005. MMWR Morb Mortal Wkly Rep. 2005;54:597–601.

    Google Scholar 

  222. Laurencin CT, Christensen DM, Taylor ED. HIV/AIDS and the African American community: a state of emergency. J Natl Med Assoc. 2008;100:35–43.

    PubMed  Google Scholar 

  223. Padian NS, Buve A, Balkus J, Serwadda D, Cates W. Biomedical interventions to prevent HIV infection: evidence, challenges, and the way forward. Lancet. 2008;372:585–99.

    Article  PubMed  CAS  Google Scholar 

  224. Nuttal J, Romano J, Douville K, et al. The future of HIV prevention: prospects for an effective anti-HIV microbicide. Infect Dis Clin North Am. 2007;21:219–39.

    Article  Google Scholar 

  225. Cutler B, Justman J. Vaginal microbicides and the prevention of HIV transmission. Lancet Infect Dis. 2008;8:685–97.

    Article  PubMed  CAS  Google Scholar 

  226. Siegfried N, Muller M, Deeks JJ, Volmink J. Male Circumcision for prevention of heterosexual acquisition of HIV in men. Cochrane Database Syst Rev. 2009; 2:CD003362. Doi: 10.1002/14651858.CD003362.pub2.

  227. Warner L, Ghanem KG, Newman DR, Macaluso M, Sullivan PS, Erbelding EJ. Male circumcision and risk of HIV infection among heterosexual African American men attending Baltimore sexually transmitted disease clinics. J Infect Dis. 2009;199:59–65.

    Article  PubMed  Google Scholar 

  228. Leibowitz AA, Desmond K, Belin T. Determinants and policy implications of male circumcision in the United States. Am J Public Health. 2009;99:138–45.

    Article  PubMed  Google Scholar 

  229. Smith DK, Taylor A, Kilmarx PH, et al. Male circumcision in the United States for the prevention of HIV infection and other adverse health outcomes: report from a CDC consultation. Public Health Rep. 2010;125 Suppl 1:72–82.

    PubMed  Google Scholar 

  230. Centers for Disease Control and Prevention. HIV prevention through early detection and treatment of other sexually transmitted diseases—United States. MMWR Morb Mortal Wkly Rep. 1998;47(No. RR-12):1–24.

    Google Scholar 

  231. Rotheram-Borus MJ, Swendeman D, Chovnick G. The past, present and future of HIV prevention: integrating behavioral, biomedical, and structural intervention strategies for the next generation of HIV prevention. Annu Rev Clin Psychol. 2009;5:143–67.

    Article  PubMed  Google Scholar 

  232. Watson-Jones D, Weiss HA, Rusizoka M, et al. Effect of herpes simplex suppression on incidence of HIV among women in Tanzania. N Engl J Med. 2008;358:1560–71.

    Article  PubMed  CAS  Google Scholar 

  233. Celum C, Wald A, Hughes J, et al. Effect of aciclovir on HIV-1 acquisition in herpes simplex virus 2 seropositive women and men who have sex with men: a randomised, double-blind, placebo controlled trial. Lancet. 1998;371:2109–19.

    Article  CAS  Google Scholar 

  234. White RG, Orroth KK, Glynn JR, et al. Treating curable sexually transmitted infections to prevent HIV in Africa. J Acquir Immune Defic Syndr. 2008;47:346–53.

    Article  PubMed  Google Scholar 

  235. Centers for Disease Control and Prevention. CDC trials of pre-exposure prophylaxis for HIV prevention; 2009. http://www.cdc.gov/hiv/resources/Factsheets/print/prep.htm Accessed 19 May 2009.

  236. Paxton LA, Hope T, Jaffe HW. Pre-exposure prophylaxis for HIV infection: what if it works? Lancet. 2007;370:89–93.

    Article  PubMed  Google Scholar 

  237. Patiel AD, Freedberg KA, Scott CA, et al. HIV preexposure prophylaxis in the United States: impact on lifetime infection risk, clinical outcomes, and cost-effectiveness. Clin Infect Dis. 2009;48:806–15.

    Article  Google Scholar 

  238. Valdiserri RO. HIV/AIDS stigma: an impediment to public health. Am J Public Health. 2002;92:341–2.

    Article  PubMed  Google Scholar 

  239. Mahajan AP, Sayles JN, Patel VA, et al. Stigma in the HIV/AIDS epidemic: a review of the literature and recommendations for the way forward. AIDS. 2008;22 Suppl 2:S67–79.

    Article  PubMed  Google Scholar 

  240. Kippax S, Holt M. The state of social and political science research related to HIV: a report for the International AIDS Society; 2009. http://www.iasociety.org.

  241. Quinn TC, Wawer MJ, Sewankambo N, et al. Viral load and heterosexual transmission of human immunodeficiency virus type 1. N Engl J Med. 2000;342:921–9.

    Article  PubMed  CAS  Google Scholar 

  242. Porco TC, Martin JN, Page-Shafer KA, et al. Decline in HIV infectivity following the introduction of highly active antiretroviral therapy. AIDS. 2004;18:81–8.

    Article  PubMed  Google Scholar 

  243. Fang CT, Hsu HM, Twu SJ, et al. Decreased HIV transmission after a policy of providing free access to highly active antiretroviral therapy in Taiwan. J Infect Dis. 2004;190:879–85.

    Article  PubMed  Google Scholar 

  244. Clements MS, Prestage G, Grulich A, Van de Ven P, Kippax S, Law MG. Modeling trends in HIV incidence among homosexual men in Australia, 1995–2006. J Acquir Immune Defic Syndr. 2004;35:401–6.

    Article  PubMed  Google Scholar 

  245. Castilla J, Romero J, Hernando V, Marincovich B, Garcia S, Rodriguez C. Effectiveness of highly active antiretroviral therapy in reducing heterosexual transmission of HIV. J Acquir Immune Defic Syndr. 2005;40:96–101.

    Article  PubMed  Google Scholar 

  246. Velasco-Hernandez JX, Gershengorn HB, Blower SM. Could widespread use of combination antiretroviral therapy eradicate HIV epidemics? Lancet Infect Dis. 2002;2:487–93.

    Article  PubMed  CAS  Google Scholar 

  247. Granich R, Gilks CF, Dye C, De Cock KM, Williams BG. Universal voluntary HIV testing with immediate antiretroviral therapy as a strategy for elimination of HIV transmission: a mathematical model. Lancet. 2009;373:48–57.

    Article  PubMed  Google Scholar 

  248. Vernazza P, Hirschel B, Bernasconi E, Flepp M. Les personnes seropositives ne souffrant d’aucune autre MST et suivant un traitment antirretroviral efficace ne transmettent pas le VIH par voie sexuelle. Bull Med Suisses. 2008;89:165–9.

    Google Scholar 

  249. Das-Douglas M, Chu P, Santos GM, et al. Decreases in community viral load are associated with a reduction in new HIV diagnoses in San Francisco. 17th conference on retroviruses and opportunistic infections; 2010. http://www.retroconference.org/2010/Abstracts/38232.htm. Accessed on 12 Mar 2010.

  250. Montaner J, Wood E, Kerr T, et al. Association of expanded HAART coverage with a decrease in new HIV diagnoses, particularly among injection drug users in British Columbia, Canada. 17th conference on retroviruses and opportunistic infections; 2010. http://www.retroconference.org/2010/Abstracts/39866.htm. Accessed 12 Mar 2010.

  251. Sheth P, Kovacs C, Kemal K, et al. Persistent HIV RNA shedding in semen despite effective ART. 16th Conference on retroviruses and opportunistic infections; 2009. http://www.retroconference.org/2009/Abstracts/35773.htm. Accessed 18 May 2009.

  252. Marcelin AG, Tubiana R, Lambert-Niclot S, et al. Detection of HIV-1 RNA in seminal plasma samples from treated patients with undetectable HIV-1 RNA in blood plasma. 16th conference on retroviruses and opportunistic infections; 2009. http://www.retroconference.org/2009/Abstracts/34040.htm. Accessed 18 May 2009.

  253. Katz MH, Schwarcz SK, Kellog TA, et al. Impact of highly active antiretroviral treatment on HIV seroincidence among men who have sex with men: San Francisco. Am J Public Health. 2002;92:388–94.

    Article  PubMed  Google Scholar 

  254. Wilson DP, Law MG, Grulich AE, Cooper DA, Kaldor JM. Relation between HIV viral load and infectiousness. Lancet. 2008;372:314–20.

    Article  PubMed  Google Scholar 

  255. Dieffenbach CW, Fauci A. Universal voluntary testing and treatment for prevention of HIV transmission. JAMA. 2009;301:2380–2.

    Article  PubMed  CAS  Google Scholar 

  256. Holtgrave DR. Strategies for preventing HIV transmission. JAMA. 2009;302:1530–1.

    Article  PubMed  CAS  Google Scholar 

  257. Rekart ML, Patrick DM, Chakraborty B, et al. Targeted mass treatment for syphilis with oral azithromycin. Lancet. 2003;361:313–4.

    Article  PubMed  CAS  Google Scholar 

  258. Pourbohloul B, Rekart M, Brunham RC. Impact of mass treatment on syphilis transmission: a mathematical model. Sex Transm Dis. 2003;30:297–305.

    Article  PubMed  Google Scholar 

  259. Kerani RP, Handsfield HH, Stenger MS, et al. Rising rates of syphilis in the era of syphilis elimination. Sex Transm Dis. 2007;34:154–61.

    Article  PubMed  Google Scholar 

  260. Hogben M, Leichliter JS. Social determinants and sexually transmitted disease disparities. Sex Transm Dis. 2008;35:S13–8.

    Article  PubMed  Google Scholar 

  261. Francis DP, Anderson RE, Gorman ME, et al. Targeting AIDS prevention and treatment toward HIV-1-infected persons. JAMA. 1989;262:2572–6.

    Article  PubMed  CAS  Google Scholar 

  262. Valdiserri RO, Holtgrave DR, West GR. Promoting early diagnosis and entry into care. AIDS. 1999;13:2317–30.

    Article  PubMed  CAS  Google Scholar 

  263. Panel on Antiretroviral Guidelines for Adults and Adolescent. Guidelines for the use of antiretroviral agents in HIV-1 infected adults and adolescents. Department of Health and Human Services. Dec 1; 2009. p. 1–161. http://www.aidsinfo.nih.gov/ContentFiles/Adultand%20AdolescentGL.pdf. Accessed 11 Jan 2010.

  264. Janssen RS, Holtgrave DR, Valdiserri RO, et al. The serostatus approach to fighting the HIV epidemic: prevention strategies for infected individuals. Am J Public Health. 2001;91:1019–24.

    Article  PubMed  CAS  Google Scholar 

  265. Centers for Disease Control and Prevention. Advancing HIV prevention: new strategies for a changing epidemic—United States, 2003. MMWR Morb Mortal Wkly Rep. 2003;52:329–32.

    Google Scholar 

  266. Weinhardt LS, Kelly JA, Brondino MJ, et al. HIV transmission risk behavior among men and women living with HIV in 4 cities in the United States. J Acquir Immune Defic Syndr. 2004;36:1057–66.

    Article  PubMed  Google Scholar 

  267. Crepaz N, Lyles CM, Wolitski RJ, et al. Do prevention interventions reduce HIV risk behaviours among people living with HIV? a meta-analytic review of controlled trials. AIDS. 2006;20:143–57.

    Article  PubMed  Google Scholar 

  268. Marks G, Crepaz N, Senterfitt W, Janssen RS. Meta-analysis of high-risk sexual behavior in persons aware and unaware they are infected with HIV in the United States: implications for HIV prevention programs. J Acquir Immune Defic Syndr. 2005;39:446–53.

    Article  PubMed  Google Scholar 

  269. Marks G, Crepaz N, Janssen RS. Estimating sexual transmission of HIV from persons aware and unaware that they are infected with the virus in the USA. AIDS. 2006;20:1447–50.

    Article  PubMed  Google Scholar 

  270. Centers for Disease Control and Prevention. Revised recommendations for HIV testing of adults, adolescents, and pregnant women in health-care settings. MMWR Morb Mortal Wkly Rep. 2006;55(RR-14):1–17.

    Google Scholar 

  271. Burke RC, Sepkowitz KA, Bernstein KT, et al. Why don’t physicians test for HIV? a review of the US literature. AIDS. 2007;21:1617–24.

    Article  PubMed  Google Scholar 

  272. Centers for Disease Control and Prevention. Persons tested for HIV—United States, 2006. MMWR Morb Mortal Wkly Rep. 2008;57:845–9.

    Google Scholar 

  273. Bartlett JG, Branson BM, Fenton K, Hauschild BC, Miller V, Mayer KH. Opt-out testing for human immunodeficiency virus in the United States: progress and challenges. JAMA. 2008;300:945–51.

    Article  PubMed  CAS  Google Scholar 

  274. Yarnall KS, Pollak KI, Ostbye T, Krause KM, Michener L. Primary care: is there enough time for prevention? Am J Public Health. 2003;93:635–41.

    Article  PubMed  Google Scholar 

  275. Kitahata MM, Gange SJ, Abraham AG, et al. Effect of early versus deferred antiretroviral therapy for HIV on survival. N Engl J Med. 2009;360:1–12.

    Article  Google Scholar 

  276. Centers for Disease Control and Prevention. Incorporating HIV prevention into the medical care of persons living with HIV: Recommendations of CDC, the Health Resources and Services Administration, the National Institutes of Health, and the HIV Medicine Association of the Infectious Diseases Society of America. MMWR Morb Mortal Wkly Rep. 2003;52(No. RR-12):1–24.

    Google Scholar 

  277. Thrun M, Cook PF, Bradley-Springer LA, et al. Improved prevention counseling by HIV care providers in a multisite, clinic-based intervention: positive steps. AIDS Educ Prev. 2009;21:55–66.

    Article  PubMed  Google Scholar 

  278. Buffardi AL, Thomas KK, Holmes KK, Manhart LE. Moving upstream: ecosocial and psychosocial correlates of sexually transmitted infections among young adults in the United States. Am J Public Health. 2008;98:1128–36.

    Article  PubMed  Google Scholar 

  279. Valdiserri RO. Sexually transmitted infections among Gay and bisexual men. In: Wolitski R, Stall R, Valdiserri RO, editors. Unequal opportunity: health disparities affecting Gay and bisexual men in the United States. Oxford, England: Oxford University Press; 2008. p. 159–93.

    Google Scholar 

  280. Stall R, Mills TC, Williamson J, et al. Association of co-occuring psychosocial health problems and increased vulnerability to HIV/AIDS among urban men who have sex with men. Am J Public Health. 2003;93:939–42.

    Article  PubMed  Google Scholar 

  281. Operario D, Smith CD, Kegeles S. Social and psychological context for HIV risk in non-Gay-identified African American men who have sex with men. AIDS Educ Prev. 2008;20:347–59.

    Article  PubMed  Google Scholar 

  282. Neaigus A, Gyarmathy A, Miller M, Frajzyngier VM, Friedman SR, Des Jarlais DC. Transitions to injecting drug use among non-injecting heroin users: social network influence and individual susceptibility. J Acquir Immune Defic Syndr. 2006;41:493–503.

    Article  PubMed  Google Scholar 

  283. Rich JA, Grey CM. Pathways to recurrent trauma among young Black men: traumatic stress, substance use, and the “Code of the Street”. Am J Public Health. 2005;95:816–24.

    Article  PubMed  Google Scholar 

  284. Hooper S, Rosser BR, Horvath KJ, Oakes JM, Danilenko G. An online needs assessment of a virtual community: what men who use the internet to seek sex with men want in internet-based HIV prevention. AIDS Behav. 2008;12:867–75.

    Article  PubMed  Google Scholar 

  285. Hightow L, Leone P, McCoy S, et al. Continued HIV transmission among African American MSM/W on North Carolina College Campuses: expanding sexual networks of internet use and crystal methamphetamine. 16th conference on retroviruses and opportunistic infections; 2009. http://www.retroconference.org/2009/Abstracts/26873.HTM. Accessed 20 May 2009.

  286. Ellis RJ, Childers ME, Chemer M, Lazzaretto D, Letendre S, Grant I. Increased human immunodeficiency virus loads in active methamphetamine users are explained by reduced effectiveness of antiretroviral therapy. J Infect Dis. 2003;188:1820–6.

    Article  PubMed  Google Scholar 

  287. Colfax G, Shoptaw S. The methamphetamine epidemic: implications for HIV prevention and treatment. Curr HIV/AIDS Rep. 2005;2:194–9.

    Article  PubMed  Google Scholar 

  288. Mansergh G, Purcell DW, Stall R, et al. CDC consultation on methamphetamine use and sexual risk behavior for HIV/STD infection: summary and suggestions. Public Health Rep. 2006;121:127–32.

    PubMed  Google Scholar 

  289. Collins CV, Hearn KD, Whittier DN, Freeman A, Stallworth JD, Phields M. Implementing packaged HIV-prevention interventions for HIV positive individuals: considerations for clinic-based and community-based interventions. Public Health Rep. 2010;125 Suppl 1:55–63.

    PubMed  Google Scholar 

  290. National Alliance of State and Territorial AIDS Directors and Kaiser Family Foundation. The National HIV Prevention Inventory: The State of HIV Prevention across the U.S.; 2009. http://www.kff.org/hivaids/prevention.cfm. Accessed 26 Feb 2010.

Download references

Author information

Authors and Affiliations

  1. U.S. Department of Health and Human Services, Office of HIV/AIDS and Infectious Disease Policy, 200 Independence Ave, S.W., Room 443H, Washington, DC, 20201, USA

    Ronald Valdiserri M.D., M.P.H.

Authors
  1. Ronald Valdiserri M.D., M.P.H.
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Ronald Valdiserri M.D., M.P.H. .

Editor information

Editors and Affiliations

  1. , Division of STD Prevention, NCHHSTP, Ctrs for Disease Control and Prevention, Clifton Road, NE 1600, Atlanta, 30333, Georgia, USA

    Sevgi O. Aral

  2. , Division of STD Prevention, NCHHSTP, Ctrs for Disease Control and Prevention, Clifton Rd., NE 1600, Atlanta, 30333, Georgia, USA

    Kevin A. Fenton

  3. Ctrs for Disease Control and Prevention, Buford Hwy 4770, Atlanta, 30341, Georgia, USA

    Judith A. Lipshutz

Rights and permissions

Reprints and permissions

Copyright information

© 2013 Springer Science+Business Media New York

About this chapter

Cite this chapter

Valdiserri, R. (2013). Preventing HIV/AIDS in the United States, 1981–2009: History in the Making. In: Aral, S., Fenton, K., Lipshutz, J. (eds) The New Public Health and STD/HIV Prevention. Springer, New York, NY. https://doi.org/10.1007/978-1-4614-4526-5_16

Download citation

  • DOI: https://doi.org/10.1007/978-1-4614-4526-5_16

  • Published:

  • Publisher Name: Springer, New York, NY

  • Print ISBN: 978-1-4614-4525-8

  • Online ISBN: 978-1-4614-4526-5

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation